e-learning
resources
Munich 2006
Monday 04.09.2006
New methods to diagnose tuberculosis infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contribution of the T-SPOT.TB assay for differentiating active
versus
latent tuberculosis infection (LTBI)
V. Bosshard, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat, J. P. Janssens (Geneva, Switzerland)
Source:
Annual Congress 2006 - New methods to diagnose tuberculosis infection
Session:
New methods to diagnose tuberculosis infection
Session type:
Oral Presentation
Number:
2176
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Bosshard, P. Roux-Lombard, T. Perneger, M. Metzger, R. Vivien, T. Rochat, J. P. Janssens (Geneva, Switzerland). Contribution of the T-SPOT.TB assay for differentiating active
versus
latent tuberculosis infection (LTBI). Eur Respir J 2006; 28: Suppl. 50, 2176
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Interferon-γ release assays (IGRA) vs. tuberculin skin testing (TST) for detecting latent tuberculosis infection (LTBI) in chronic hemodialysis (CH) patients
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016
QuantiFERON-TB GIT (QFT-GIT)
vs
TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB)
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011
A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016
The value of tuberculin skin test (TST) and interferon – gamma release assay (IGRA) in the diagnosis of latent tuberculosis infection (LTBI) according to age group
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Interferon-γ release assays (IGRA) for detecting latent tuberculosis (LTBI) after lung transplantation (LTX)
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept